Raymond James (RJF) Competitors

Raymond James (NYSE:RJF) and Nomura (NYSE:NMR) are both large-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Does the MarketBeat Community believe in RJF or NMR?

Raymond James received 390 more outperform votes than Nomura when rated by MarketBeat users. Likewise, 59.30% of users gave Raymond James an outperform vote while only 54.15% of users gave Nomura an outperform vote.

Company	Underperform	Outperform
Raymond James	Outperform Votes 625 59.30%	Underperform Votes 429 40.70%
Nomura	Outperform Votes 235 54.15%	Underperform Votes 199 45.85%

Do analysts rate RJF or NMR?

Raymond James currently has a consensus price target of $123.88, indicating a potential upside of 0.22%. Given Raymond James' higher possible upside, equities analysts plainly believe Raymond James is more favorable than Nomura.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Raymond James	0 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.22
Nomura	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is RJF or NMR more profitable?

Raymond James has a net margin of 12.81% compared to Nomura's net margin of 3.49%. Raymond James' return on equity of 17.95% beat Nomura's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Raymond James	12.81%	17.95%	2.31%
Nomura	3.49%	3.44%	0.22%

Which has more volatility & risk, RJF or NMR?

Raymond James has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, Nomura has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500.

Is RJF or NMR a better dividend stock?

Raymond James pays an annual dividend of $1.80 per share and has a dividend yield of 1.5%. Nomura pays an annual dividend of $0.09 per share and has a dividend yield of 1.6%. Raymond James pays out 22.6% of its earnings in the form of a dividend. Nomura pays out 33.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Does the media prefer RJF or NMR?

In the previous week, Raymond James had 6 more articles in the media than Nomura. MarketBeat recorded 7 mentions for Raymond James and 1 mentions for Nomura. Nomura's average media sentiment score of 1.05 beat Raymond James' score of 0.77 indicating that Nomura is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Raymond James	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nomura	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders have more ownership in RJF or NMR?

83.8% of Raymond James shares are owned by institutional investors. Comparatively, 15.1% of Nomura shares are owned by institutional investors. 9.7% of Raymond James shares are owned by company insiders. Comparatively, 0.0% of Nomura shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has preferable valuation & earnings, RJF or NMR?

Raymond James has higher revenue and earnings than Nomura. Raymond James is trading at a lower price-to-earnings ratio than Nomura, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Raymond James	$12.99B	1.99	$1.74B	$7.98	15.49
Nomura	$9.89B	1.75	$686.62M	$0.27	21.37

Summary

Raymond James beats Nomura on 16 of the 20 factors compared between the two stocks.